GC MediAI Launches Solution for Monitoring Alternative Dispensing Occurrence

Supporting Pharmaceutical Companies in Developing Sales and Marketing Strategies

GC MediAI announced on the 7th that it has launched "UBIST Pharmacy Substitution," a solution for monitoring the occurrence of alternative dispensing.

This service analyzes the inflow and outflow status of products occurring at the pharmacy level based on a panel dataset of 4,340 pharmacies nationwide. Pharmaceutical companies can check which competing products their own products have been substituted with during alternative dispensing, as well as the scale at which their own products have replaced competitors' prescriptions.

GC MediAI has launched 'UBIST Pharmacy Substitution,' a solution for substitution dispensing status. GC MediAI

First, users can set and analyze the original prescription and actual dispensing conditions based on criteria such as distributor, product, ATC code, and ingredient. Through this, it is possible to examine the overall status of alternative dispensing in a specific ingredient market, and understand if alternative dispensing to competing products is being concentrated in core items.

Medical institution type data and regional data can also be cross-checked, enabling users to identify regions where prescription outflow and product inflow are concentrated, and segment sales and marketing target areas accordingly. The number of alternative prescriptions, alternative dispensing volume, and alternative dispensing amount are all provided as exact figures and as ratios.

Jintae Kim, CEO of GC MediAI, commented, "As telemedicine expands and the non-reimbursed market grows, the gap between prescription and dispensing will widen, further increasing the need for data utilization. We aim to help transform the changes in the alternative dispensing system into new business opportunities rather than treating them as risks."

This content was produced with the assistance of AI translation services.